QYUNS-B completes the placement of 5 million shares

智通財經
2025.08.25 13:35
portai
I'm PortAI, I can summarize articles.

荃信生物-B 完成配售 500 萬股，配售價每股 20.0 港元，承配人為 TruMed Health Innovation Fund LP。配售事項於 2025 年 8 月 25 日完成，配售股份佔配售前已發行股份數目約 2.25%，配售後約 2.20%。

智通財經 APP 訊，荃信生物-B(02509) 發佈公告，配售協議所載的所有條件已獲達成，而配售事項完成已根據配售協議的條款於 2025 年 8 月 25 日落實。

根據配售協議的條款及條件，配售代理已成功按配售價每股配售股份 20.0 港元向一名承配人 (即 TruMed Health Innovation Fund LP) 配售合共 500 萬股配售股份，佔 (i) 緊接配售事項完成前已發行股份數目約 2.25%;及 (ii) 緊隨配售事項完成後經配發及發行配售股份擴大後的已發行股份數目約 2.20%。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.